Zydus has launched Tishtha, an affordable biosimilar of nivolumab, at nearly one-fourth the original price. Approved by the ...

D Path, a company dedicated to personalizing cancer care through a novel, physics-inspired approach to predicting tumor response to therapy, today announced its participation as an exploratory ...

IMMUNOLIFE, a Phase 2 randomized exploratory study, will evaluate the potential of MaaT033 in combination with Cemiplimab versus Best Investigator Choice (i.e.: second line) in enhancing disease ...

MaaT Pharma Announces First Patient Randomized in IMMUNOLIFE Phase 2 Study Sponsored by Gustave Roussy, in Advanced NSCLC ...

The last thing you want to hear when you’re feeling down is something like “chin up” or “just think positive.” But there may ...

The Southern Arizona DUI Task Force patrolled Tucson and surrounding areas over the holiday weekend, looking to detect and deter drunken driving. The task force used sobriety checkpoints and ...

Researchers highlight how exercise and dietary strategies may complement immunotherapy by improving immune function, tumour perfusion, and quality of life.

Study subject Remains in Complete Response for 3 YearsExceeds Expectations in Platinum-Resistant Ovarian Cancer Compared to Standard of Care Single-Agent ChemotherapyVancouver, British ...

Creative Biolabs announced the launch of its OncoVirapy™ platform, which offers a highly competitive one-stop service for ...

Uganda and Tanzania governments have yet to learn a fundamental truth: silencing your ...

Greenway Health, the modern leader in healthcare technology, today announced the launch of its Agentic AI Factory, developed in collaboration with Amazon Web Services (AWS). The Agentic AI Factory is ...